Insider buying
~$300K32K sh @ $9.30
First insider buy since Nov 2023Traded Nov 13 · filed 3 days later
Since the trade −11.3% · S&P 500 −3.2% · to Nov 18
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CTVA · NYSE · Fertilizers & Agricultural Chemicals
Corteva (CTVA) · oqro.io/stocks/CTVA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Baskets of the companies that insiders, members of Congress or funds recently reported buying, each held under a written rule.
Yes. Insiders of Corteva (CTVA) filed 3 open-market purchases in the last 90 days; the latest was filed on Nov 16, 2026.
Since 2019, Corteva insiders reported 35 open-market purchases and 23 sales on Forms 4 and 5, with purchases in 6 different years, most recently 2026.
No open-market sale by an insider of Corteva (CTVA) was filed with the SEC in the last 90 days.
Yes. Members of Congress disclosed 4 trades in Corteva (CTVA) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Rep. Gilbert Ray Cisneros Jr. (CA31), Sen. Alan Armstrong, Sen. Gary C. Peters.
Corteva's next results are expected on Feb 1, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$8.36−0.46 (−5.22%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
−87.0% (−$56.14) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $64.50 on Nov 18, 2025 to $8.36 on Nov 18, 2026 (−87.0%). Disclosed in this range: 5 insider trades, 0 pre-arranged insider sales, 4 Congress trades, and 55 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Fertilizers & Agricultural Chemicals company based in Indianapolis, Indiana.
Last 12 months
−87.0%
Market value
$5.58B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 51M shares sold short (7.6% of shares outstanding), +32.2% vs the previous count, 2.7 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$2.46B
−6.1% vs the same quarter a year earlier
Free cash flow, last 12 months
−$149M
This quarter −$742M, a year earlier $36M
Net cash
$474M
Debt $3.46B, cash $3.93B, at Sep 30, 2026
Backlog
$158M
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 12, 2026.
Revenue, fiscal 2025
$17.4B
+2.9% vs the year before
Net income, fiscal 2025
$1.09B
As reported in the annual filing
Shares outstanding
667M
As of Nov 5, 2026
In fiscal 2025 the company spent $1.07B buying back its own shares and $475M on dividends. Cash actually paid, from its cash-flow statement.
Insider buying
First insider buy since Nov 2023Traded Nov 13 · filed 3 days later
Since the trade −11.3% · S&P 500 −3.2% · to Nov 18
Traded Nov 13 – Nov 16, 2026 · largest single transaction ~$93K
Nov 16, 2026~$93K · 10K sh @ $9.25
DetailsOfficial recordNov 13, 2026~$93K · 10K sh @ $9.29
DetailsOfficial recordFund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Congress
Traded Oct 14 · disclosed 27 days later
Since the trade −37.6% · S&P 500 −5.1% · to Nov 18
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
FMR LLC
Schedule 13G: passive · filed Nov 6, 2026 · 69M shares
BlackRock, Inc.
Schedule 13G: passive · filed Nov 4, 2026 · 68.1M shares
Capital World Investors
Schedule 13G: passive · filed Nov 13, 2026 · 50.6M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 29, 2026 · 50.8M shares
STATE STREET CORPORATION
Schedule 13G: passive · filed Nov 10, 2025 · 35.3M shares
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Insiders of Corteva reported 35 open-market purchases and 23 sales since 2019; purchases in 6 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $486K3×3 trades | $636K2×2 trades |
| 2025 | — | $11.2M4×4 trades |
| 2024 | — | $7.18M5×5 trades |
| 2023 | $2.81M6×6 trades | — |
| 2022 | $2.56M2×2 trades | $6.48M4×4 trades |
| 2021 | $279K2×2 trades | $1.66M2×2 trades |
| 2020 | $1.95M11×11 trades | $1.77M6×6 trades |
| 2019 | $1.41M11×11 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Said its annual or quarterly report would be late
“Corteva, Inc. and EIDP, Inc. (the “Companies”) are unable to file their Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026 by the prescribed due date without unreasonable effort or expense as the Companies require additional time to complete certain processes and procedures related to the required reporting resulting from the spin-off of the Companies’ seed operating segment completed on”
NT 10-Q on sec.govLarge write-down of assets
8-K/A on sec.govTop officer leaving
“He previously served as President and CEO of Albemarle Corporation, a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts, from September 2011 until his retirement in June 2020.”
1 insider sold ~$636K in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Last results
Nov 12, 2026
Within the 30 days after it, until Dec 12, 2026
Next results, expected
Feb 1, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
97%
32 of 33 insider purchases since 2019 came within 30 days after a results announcement
From Corteva's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Corteva's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Short sale volume: 27.8% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 41.6%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 194K shares (about $2.22M) were not delivered on time for settlement on Oct 30, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.